Navigation Links
Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
Date:9/4/2013

merica today[i]. Coronary artery disease is the most common type of heart disease and is caused by atherosclerosis and often develops into angina pectoris and MI. This condition can lead to angina pectoris and MI and caused more than 405,000 deaths in 2008[ii]. Roughly 16.8 million people have a history of MI and/or angina[iii]. An estimated 24 million have been identified as secondary prevention patients (post-event)[iv]. It is estimated that cardiovascular disease causes one in every three deaths in the United States[v]. Every 25 seconds, someone in the United States will suffer a coronary event[vi]. About every minute, someone will die from one[vii].

About POZENPOZEN Inc. is a small pharmaceutical company that specializes in developing novel therapeutics for unmet medical needs and licensing those products to other pharmaceutical companies for commercialization. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products in two years. Funded by these milestones/royalty streams, POZEN is creating a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.

POZEN continues to seek strategic partners to help maximize the opportunities for its portfolio assets.

The Company's common stock is traded under the symbol "POZN" on The NASDAQ Global Market. For more detailed company information, including copies of this and other press releases, please visit www.pozen.com.

About SanofiSanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal heal
'/>"/>

SOURCE Sanofi US
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteurs Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older
2. Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.
3. Sanofi US and Joslin Diabetes Center Announce Results from Multicultural Outreach Pilot at American Diabetes Association Scientific Sessions
4. Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
6. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
7. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
8. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
9. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
10. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
11. NextBio Announces Translational Medicine Partnership with Sanofi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015  Kannalife Sciences, Inc. ("Kannalife") announces ... its Scientific Advisory Board to assist the Company in ... the use of cannabinoid therapeutics for the treatment of ... pathologist responsible for conducting the full autopsy of ... center for the Pittsburgh Steelers. It was through his ...
(Date:3/4/2015)... 4, 2015  Heska Corporation (Nasdaq: HSKA ... to Join Its Fourth Quarter and Year End 2014 ... @ 9:00 a.m. (MST) / 11:00 a.m. (EST)Where: www.heska.com ... Earnings Call link on the front page of this ... the web at the address above.  Alternatively, you may ...
(Date:3/4/2015)... 4, 2015  Halyard Health, Inc. (NYSE: ... its 2015 outlook and related key planning assumptions. ... as we report our fourth quarter results, our first ... CEO. "We executed a smooth separation from Kimberly-Clark and ... We delivered sales growth and margin improvement in the ...
Breaking Medicine Technology:Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 3Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 4Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 5Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 6Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 7Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 8Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 9Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 10Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 11Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 12Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 13Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 14Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 15Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 16Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 17Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 18Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 19Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 20Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 21Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 22Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 23Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 24Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 25Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 26Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 27Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 28Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 29Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 30Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 31
... NATICK, Mass., March 1, 2012  Boston Scientific Corporation ... of the PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary ... approved by the Ministry of Health, Labor and ... platinum chromium (PtCr) alloy with an innovative stent ...
... 1, 2012  Nouveau Life Pharmaceuticals, soon to be changed from ... today that it is hiring a team of consumer marketing ... and pending portfolio of products to the market place. ... the brand and consumer education strategy for the Azul Instant™ ...
Cached Medicine Technology:Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan 2Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan 3Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan 4HRID Announces Growth and Expansion 2HRID Announces Growth and Expansion 3
(Date:3/5/2015)... March 05, 2015 Lakeview Regional ... support of the annual American Heart Association’s Heart Walk ... Kolman, Lakeview Regional Chief Executive Officer, is serving as ... Saturday, March 21, 2015 at Fontainebleau State Park beginning ... Regional has 20 individual teams participating in this year’s ...
(Date:3/5/2015)... The pleasing melodies of live bluegrass music will ... bicycle and hand cycle ride as they arrive in Frederick, ... String Band will present a free concert for riders ... Pentagon in Arlington, Virginia. , “We are thrilled and honored ... have sacrificed so much. We love being to give back ...
(Date:3/5/2015)... 2015 In recognition of its ongoing ... Soho Flordis International (SFI) has been honored by the ... global natural medicine company committed to identifying and developing ... safety, and effectiveness. For these efforts the non-profit ABC ... Investment in Phytomedicinal Research Award. , Phytomedicinal research ...
(Date:3/5/2015)... New Brunswick (PRWEB) March 05, 2015 ... help validate product innovations as the company prepares to ... will be comprised of individuals in the Life Sciences ... working with our clients,” said Elandas CEO Ryan Roberts. ... as a successful organization through our collaborative efforts. As ...
(Date:3/4/2015)... Imagine No Malaria’s 2014 World Malaria Day campaign has been ... honor given to nonprofit causes that make a difference. The ... (NTC15) in Austin, Texas. The Rev. Bobbi Kaye Jones, ... on hand for the presentation; she is a member of ... Malaria was one of five finalists selected by Care2, a ...
Breaking Medicine News(10 mins):Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 2Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 3Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 2Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 3Health News:Elandas Creates Advisory Board to Help Guide Innovation 2Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3
... ... current overview and future projections of the US hospital information technology market , ... Chicago, IL (Vocus) June 2, 2009 -- ... electronic medical record, HIMSS Analytics cuts through the information clutter to clarify which ...
... 2 Darwin National,Assurance Company, a member company of ... AWH ), today announced that Kim Lloyd, Vice President,Healthcare ... at the American Hospital Association (AHA) Solutions Roundtable in,Chicago ... "Market, Claims,and Healthcare Risk Management Update - Measuring Your ...
... solution - Premerus(SM) Diagnostic Accuracy - at AHIP; demonstrates key ... , , FRANKLIN, Tenn., June 2 ... of medical cost management services, will highlight its groundbreaking solution ... America,s Health Insurance Plans (AHIP) Institute 2009. An industry first, ...
... 28, 2009Scientists at Columbia University,s Mailman School of ... Communicable Diseases of National Health Laboratory Service (NICD-NHLS), ... and Roche,s 454 Life Sciences Corporation have discovered ... hemorrhagic fever outbreak in Zambia and South Africa ...
... HARRISBURG, Pa., June 2 Governor Edward G. ... for the Lottery-funded PACENET prescription drug benefit for older Pennsylvanians, ... or no drug coverage now. , , "As ... economic times, providing comprehensive prescription medication coverage is more important ...
... top priority for PA Professional Fire Fighters Association through ... , HARRISBURG, Pa., June 2 The Pennsylvania ... will become the first Fire Fighter State Association to ... This program is part of its long standing commitment ...
Cached Medicine News:Health News:Understand ARRA Spending Allocations with HIMSS Analytics™ Market Intelligence 2Health News:Understand ARRA Spending Allocations with HIMSS Analytics™ Market Intelligence 3Health News:Darwin's Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009 2Health News:Darwin's Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009 3Health News:MedSolutions: Accurate Diagnosis Is Critical to Reducing Healthcare Costs 2Health News:MedSolutions: Accurate Diagnosis Is Critical to Reducing Healthcare Costs 3Health News:MedSolutions: Accurate Diagnosis Is Critical to Reducing Healthcare Costs 4Health News:New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia 2Health News:New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia 3Health News:Governor Rendell Proposes Offering Prescription Help to 30,000 More Older Adults as Part of Plan to Save $60 Million 2Health News:PA Professional Fire Fighters Association is First State Association in Nation to Offer Smoking Cessation Program 2Health News:PA Professional Fire Fighters Association is First State Association in Nation to Offer Smoking Cessation Program 3Health News:PA Professional Fire Fighters Association is First State Association in Nation to Offer Smoking Cessation Program 4
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 230 V, 50 Hz gel drying oven....
... The PRO6000 power supply is ... power supply product offering. It ... and genomic electrophoresis. This product ... proteomic applications such as microAmp ...
... Operating as a constant voltage power supply, the ... knob and hilo range switch control the output, ... to 250 volts. One, two-position switch toggles the ... output current. The 105 is equipped with an ...
... The 250-90 low voltage electrophoresis power supply ... 500 milliamps and 125 watts. This product operates ... continuously variable output. The 250-90 automatically crosses over ... when a preset limit is reached. ...
Medicine Products: